Journal of Mass Spectrometry and Advances in the Clinical Lab
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.7 | Q2 | 72.7% | 0.743 | Q1 | 74.9% |
| 2024 | 3.4 | Q2 | 75.8% | 0.712 | Q1 | 74.1% |
| 2023 | 3.1 | Q2 | 71.4% | 0.762 | Q1 | 78.3% |
| 2022 | 2.2 | Q3 | 63.6% | 0.447 | Q2 | 62.8% |
| 2021 | — | 14.3% | 0.436 | Q2 | 62.9% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2667-1468
ISSN
2667-145X
region
Western Europe
coverage
2021-2025